Jesús Merayo Lloves-rekin lankidetzan egindako argitalpenak (24)

2022

  1. Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus

    Expert Opinion on Biological Therapy, Vol. 22, Núm. 1, pp. 31-45

2021

  1. Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases

    International Ophthalmology, Vol. 41, Núm. 7, pp. 2347-2358

2020

  1. Plasma rich in growth factors for the treatment of cicatrizing conjunctivitis

    Clinical Ophthalmology, Vol. 14, pp. 1619-1627

  2. Plasma rich in growth factors for the treatment of dry eye from patients with graft versus host diseases

    European Journal of Ophthalmology, Vol. 30, Núm. 1, pp. 94-103

  3. Potential Effect of Plasma Rich in Growth Factors-Endoret in Stromal Wound Healing in Additive Surgery

    Ophthalmic Research, Vol. 63, Núm. 2, pp. 203-212

2018

  1. Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF)

    PLoS ONE, Vol. 13, Núm. 10

  2. Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma

    International Medical Case Reports Journal, Vol. 11, pp. 97-103

  3. Plasma rich in growth factors for the treatment of dry eye after LASIK surgery

    Ophthalmic Research, Vol. 60, Núm. 2, pp. 80-86

  4. Plasma rich in growth factors membrane as coadjuvant treatment in the surgery of ocular surface disorders

    Medicine (United States), Vol. 97, Núm. 17

  5. Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops

    International Ophthalmology, Vol. 38, Núm. 3, pp. 1193-1204

2017

  1. Allogeneic blood-based therapies: Hype or hope?

    Eye (Basingstoke)

  2. Autologous method for ex vivo expansion of human limbal epithelial progenitor cells based on plasma rich in growth factors technology

    Ocular Surface, Vol. 15, Núm. 2, pp. 248-256

  3. The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome

    Journal of Ocular Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 391-399

2016

  1. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders

    Ophthalmic Research, Vol. 55, Núm. 2, pp. 53-61

  2. PRGF exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model

    Experimental Eye Research, Vol. 151, pp. 115-121

  3. Plasma Rich in Growth Factors for the Treatment of Ocular Surface Diseases

    Current Eye Research, Vol. 41, Núm. 7, pp. 875-882

  4. Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye

    Ophthalmic Research, Vol. 56, Núm. 2, pp. 68-73

2015

  1. Autologous serum and plasma rich in growth factors in ophthalmology: Preclinical and clinical studies

    Acta Ophthalmologica, Vol. 93, Núm. 8, pp. e605-e614

  2. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts

    Experimental Eye Research, Vol. 135, pp. 118-126

  3. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops after Their Different Time and Temperature Conditions of Storage

    Cornea, Vol. 34, Núm. 9, pp. 1144-1148